1. Introduction {#section0005}
===============

Community-acquired pneumonia (CAP) is one of the most common acute lung diseases detected by radiographic abnormalities. In the management of CAP, pneumonias have been categorized into two groups based on sensitivity to antibiotics: bacterial pneumonia, which responds to the beta-lactam antibiotics, and non-bacterial pneumonia, which is non-responsive. Although new macrolides and new quinolones are considered to be effective therapeutic agents for non-bacterial pneumonias as well as for most of bacterial pneumonias, the recent emergence and spread of bacteria resistant to these drugs, especially in Asia including Japan, have raised significant worldwide concern [@bib1], [@bib2]. Therefore, the differentiation of these two types of pneumonias is recommended in the guidelines for the management of CAP from the Japanese Respiratory Society [@bib3]. However, even the combined study of clinical manifestations and laboratory screenings such as blood cell counts and serum chemistries have yielded no information specific to either type of pneumonia. Moreover, studies on chest radiography have also failed to elucidate any precise differences [@bib4].

Recent advances in computed tomography (CT) are now enabling the evaluation of normal or questionable radiographic findings [@bib5]. Thin-section CT improves the characterization of parenchymal infections and their complications in the management of lung infections [@bib6]. In recent years, investigators have focused on radiologic findings of pneumonia caused by specific pathogens such as *mycoplasma* and *chlamydia* and the characteristics of these pneumonias have been described [@bib5], [@bib7], [@bib8], [@bib9]. During the recent epidemic of severe acute respiratory syndrome (SARS), the use of chest CT in combination with clinical findings was reported to be useful in ruling out a number of differential diagnoses [@bib10]. Thin-section CT may have advantages over conventional chest radiography in the etiologic diagnosis of CAP. However, we are not aware of any prospective study investigating the usefulness of thin-section CT as a possible modality for distinguishing the different pathogens of pneumonia. The aim of this study was to elucidate the differences in thin-section CT findings between bacterial and non-bacterial pneumonia. As a part of this study, differences between two representative forms of CAP, i.e., pneumococcal pneumonia and mycoplasmal pneumonia, were also examined [@bib11].

2. Methods {#section0010}
==========

2.1. Patients {#section0015}
-------------

Patients enrolled in the present thin-section CT study were part of our ongoing long-term, prospective study to detect etiological microorganisms in CAP cases at our hospital (a general teaching hospital with 1151 beds) since July 1994 [@bib11]. The present study was conducted between January 1998 and June 2001. The candidates for enrollment were the same candidates from the etiological study reported previously, i.e., all hospitalized CAP patients over 15 years of age [@bib11]. CAP patients were designated as those who developed symptoms outside of any hospital or healthcare institution and presented with symptoms of respiratory infection such as cough, sputum or dyspnea, and infiltrate on chest radiography. Conventional chest CT and thin-section CT evaluations were performed on the hospitalized CAP patients who gave their informed consent. Prior to the study, the protocol was approved by the institutional review board. Patients were excluded from this study if they had at least one of the following conditions: inability to hold one's breathing sufficiently to perform a chest CT, shock, consciousness disturbance, thoracic deformity, an underlying lung disease (pulmonary emphysema, bronchiectasis, interstitial pneumonia, old tuberculosis, etc.) that could skew the thin-section CT findings, an underlying immunodeficiency and possible pregnancy. Patients with lung diseases that were localized apart from pneumonia or minor underlying lung diseases that were not considered to affect the thin-section CT findings were included.

A total of 390 patients (273 men and 117 women) who had experienced 403 episodes of CAP were enrolled in this study. Among the 403 CAP cases, 288 (285 patients) were examined by chest CT. Next, 183 cases (181 patients, 125 men and 56 women, mean age ± S.D.: 61.1 ± 19.7) that did not qualify for the exclusion criteria described below in Section [2.3](#sec1){ref-type="sec"} were examined by thin-section CT, and the thin-section CT findings were assessed by two radiologists.

2.2. Determination of the causative microorganisms {#section0020}
--------------------------------------------------

Microbiological and serological studies were performed on all hospitalized CAP patients as described previously [@bib11]. Pneumonias caused by *Streptococcus pneumoniae* (*S. pneumoniae*) or other bacteria were diagnosed based on at least one of the following tests: blood culture, culture of needle aspiration fluid from pleural effusion or lung, quantitative culture of sputum or bronchoalveolar lavage fluid, and urinary antigen test (Binax NOW^®^ *S. pneumoniae* Urinary Antigen Test, Binax, Portland, ME). Specific serological methods were employed for diagnosis of non-bacterial pneumonias [@bib12]. Pneumonia caused by *Mycoplasma pneumoniae* (*M. pneumoniae*) was diagnosed by a four-fold rise in the antibody titers (passive hemagglutinin test or complement fixation test) or by culture of sputum or pharyngeal swab [@bib13].

Among the 183 cases examined by thin-section CT, 65 (63 patients) were diagnosed as pneumococcal pneumonia (including 6 co-infected with other organisms), 20 (20 patients) were diagnosed as mycoplasmal pneumonia, 43 were diagnosed as other infections, and 55 could not be etiologically confirmed ([Table 1](#tbl1){ref-type="table"} ). Causal microorganisms were categorized into two types of pathogens: bacterial (*Streptococcus* spp., *Haemophilus influenzae* \[*H. influenzae*\], *Moraxella catarrhalis*, *Escherichia coli*, *Staphylococcus aureus*, anaerobes and *Klebsiella pneumoniae*) and non-bacterial (*M. pneumoniae*, *Chlamydia* spp., *Influenza* virus and *Measles* virus) [@bib4], [@bib6]. Before the analysis, clinicians excluded three cases: one who turned out to be co-infected with both bacterial and non-bacterial pathogens, one diagnosed with *Legionella* pneumonia and one with tuberculosis. Thus, the final analysis included etiologically confirmed thin-section CT findings on 94 bacterial and 31 non-bacterial pneumonias, including 59 pneumococcal and 20 mycoplasmal pneumonias. Radiologists diagnosed minor underlying lung diseases in 42 of the 183 CAP cases examined by thin-section CT (25 with emphysema, 9 with lung fibrosis, 4 with old tuberculosis, 3 with bronchiectasis, and 1 with lung cancer).Table 1Etiology of 183 CAP episodes in which thin-section CT was obtainedEtiologyNumber of casesProven128 *Streptococcus pneumoniae*65 (51%)  Without co-infections59  With co-infections6   *Mycoplasma pneumoniae*20 (16%)   *Haemophilus influenzae*12 (9%)   *Chlamydia pneumoniae*7 (5%)   *Streptococcus milleri* group4 (3%)   Miscellaneous18 (14%)   Co-infections2 (2%)  Unproven55

2.3. Chest thin-section CT study {#sec1}
--------------------------------

Conventional chest CT and thin-section CT scans were performed within 2 days of hospital admission (mean 1.1 days) with the patient in a supine position. One of the following three scanners was used: HiSpeed Advantage (General Electric Medical Systems, Milwaukee, WI), PQ5000 (Picker International, Cleveland, OH), or Asteion (Toshiba Medical Systems, Tokyo, Japan). All images were routinely obtained with 8--10-mm collimation at 10-mm intervals. Patients who were unable to hold their breath or found to have an underlying lung disease causing marked distortion of the lung architecture, massive pleural effusion causing passive atelectasis, or empyema on the routine chest CT examination were excluded from further thin-section CT study. The thin-section CT images were obtained with 1--3-mm collimation at 10 mm intervals, at a field of view of 20 cm. The images were reconstructed using a high-spatial-frequency algorithm and photographed at window settings for evaluation of the lung parenchyma (−700 HU \[level\] and 1500--1800 HU \[width\]) and the mediastinum (10 HU \[level\] and 300 HU \[width\]). Intravenous contrast medium was not used.

2.4. Image analysis {#section0025}
-------------------

Image analysis was done retrospectively following prospective enrollment of the patients and collection of the CT images. Hard copies of chest CT scan images were read on film and were assessed separately by two experienced chest radiologists blinded to the patients' data, clinical conditions, and chest roentogenography. After their independent readings, any differences in findings were checked. They then re-assessed the films in question together and final decisions were reached by consensus. The radiologists assessed the presence, location, and extent of the findings according to the previously reported descriptions [@bib6], [@bib14]. Areas of airspace consolidation (AS), areas of ground-glass attenuation (GG), lobular opacity, airspace nodules, centrilobular nodules, and thickening of bronchovascular bundles (BVB) were assessed at the window setting for the lung parenchyma. Lobar pneumonia was defined as AS, GG or a mixture of the two occupying more than 70% of the area of one lobe. Mediastinal adenopathy (larger than 10 mm) and pleural effusion were assessed at the window setting for the mediastinum. The criteria for interpreting the findings are summarized in [Table 2](#tbl2){ref-type="table"} .Table 2Summary of thin-section CT findingsFindingInterpretation criteriaAreas of airspace consolidationIncreased lung opacity with obscuration of vascular markingsAreas of ground-glass attenuationHazy increased lung opacity without obscuration of vascular markingsLobular opacityOpacity demarcated by interlobular bordersAirspace nodulesSmall nodule 3--10 mm in diameter, ill-defined, accompanied with obscured small vesselsCentrilobular nodulesMicronodule less than 3 mm in diameter located in the centrilobular areaThickening of BVBBronchial wall thickened by more than 25% of the diameter of the airway luminaAir-bronchogramAir-filled bronchus visible in parenchymal opacityAtelectasisSmall or large section of collapsed lung without a gas-containing parenchymaInterlobular septal thickeningThickened septa 1--2 cm in length outlining part of or entire lobuleMediastinal adenopathyMediastinal lymph nodes larger than 10 mm[^6]

To assess the location of each radiological finding for thin-section CT, the lung parenchyma from the mediastinum to the pleura was divided into three zones of equal width (inner, middle and outer zones). Thin-section CT findings of areas of AS, GG, lobular opacity, airspace nodules, and centrilobular nodules were each classified into three distributional patterns, based on the predominant locations of each type of shadow. Each type of shadow was also assessed to determine whether it appeared unilaterally or bilaterally.

2.5. Statistical analysis {#section0030}
-------------------------

To identify the candidate radiological predictors for bacterial pneumonia versus non-bacterial pneumonia, and for pneumococcal pneumonia versus mycoplasmal pneumonia, statistical differences in the frequencies and distributions of thin-section CT findings were determined by either the chi-square test or Fisher's exact probability test. A *p*  \< 0.05 was considered to indicate statistical significance. Candidate predictors with *p*  \< 0.10 were selected and used in multivariate logistic regression analysis to construct the prediction equations for bacterial pneumonia versus non-bacterial pneumonia (model 1, with or without underlying lung diseases; model 2, without underlying lung diseases), and pneumococcal pneumonia versus mycoplasmal pneumonia (model 3). Standard errors (S.E.), *p*-values of the likelihood ratio test, and estimated coefficients for independent variables (*β*) were determined. Probabilities of bacterial pneumonia (model 1 and 2) and pneumococcal pneumonia (model 3) were calculated for all patients in each group using the logistic model *P*  = 1 − 1/(1 +  *e* ^*r*^) and *r*  = \[*k*  + Σ*β* ~*i*~  × (0 or 1)\]. The receiver operating characteristic (ROC) curves were generated using the models. StatView^®^ version 5.0 (SAS Institute Inc., Cary, NC) was used for all of the statistical calculations. The degree of interobserver agreement between the two readers was assessed with the *κ* statistic: poor, *κ*  = 0--0.20; fair, *κ*  = 0.21--0.40; moderate, *κ*  = 0.41--0.60; good, *κ*  = 0.61--0.80; excellent, *κ*  = 0.81--1.00.

3. Results {#section0035}
==========

3.1. Thin-section CT findings {#section0040}
-----------------------------

[Table 3](#tbl3){ref-type="table"} shows the frequency of thin-section CT findings in each etiological group. No specific findings predictive of certain organisms were found. The only difference between thin-section CT manifestations of *H. influenzae* pneumonia and pneumococcal pneumonia was in the detection of lobar pneumonia: zero out of 12 (0%) in the former versus 20 out of 59 (34%) in the latter. Thin-section CT findings on chlamydial pneumonia were non-specific, with relatively less frequent airspace nodules, lobular opacity, and centrilobular nodules compared to mycoplasmal pneumonia. However, in comparing bacterial and non-bacterial pneumonia, several of the findings were found to occur at significantly different frequencies. Lobular opacity, centrilobular nodules, and thickening of bronchovascular bundles were more frequent in non-bacterial pneumonia (*p*  = 0.002, *p*  = 0.001 and *p*  = 0.001, respectively) ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"} ). Prominent centrilobular nodules appeared as the main shadow more frequently in non-bacterial pneumonia cases in 7 out of 31 (23%) (*p*  = 0.001), with a specificity of 98% (92 out of 94) ([Fig. 2](#fig2){ref-type="fig"}). Areas of AS and areas of 'GG located around AS' were more frequently observed in bacterial pneumonia (*p*  = 0.017 and *p*  = 0.039, respectively) ([Fig. 4](#fig4){ref-type="fig"} ), but these findings were non-specific. Airspace nodules in bacterial pneumonia ([Fig. 5](#fig5){ref-type="fig"} ) and centrilobular nodules in non-bacterial pneumonia ([Fig. 3](#fig3){ref-type="fig"}) tended to be located in the outer areas of the lung parenchyma (*p*  = 0.023 and *p*  = 0.001), with high specificities of 94% (29 out of 31) and 89% (84 out of 94) despite low sensitivities of 26% (24 out of 94) and 39% (12 out of 31), respectively. Bilateral centrilobular nodules were seen more frequently in non-bacterial pneumonia (*p*  = 0.007), with a sensitivity of 32% (10 out of 31) and specificity of 90% (85 out of 94). Interlobular septal thickening tended to be seen more often in bacterial pneumonias (*p*  = 0.087) ([Fig. 6](#fig6){ref-type="fig"} ). The interobserver agreements (*κ* statistics) for the thin-section CT findings were 0.68 for centrilobular nodules, 0.50 for airspace nodules, 0.53 for lobular opacity, 0.71 for areas of AS, and 0.64 for areas of GG.Table 3Frequency of thin-section CT findingsFindingEtiology[a](#tbl3fn1){ref-type="table-fn"}UnBac versus NonBacterial (*n* = 94)Non-bacterial (*n* = 31)TotalS.pnH. infTotalM.pnChl.spp.94[b](#tbl3fn2){ref-type="table-fn"}59[b](#tbl3fn2){ref-type="table-fn"}12[b](#tbl3fn2){ref-type="table-fn"}31[b](#tbl3fn2){ref-type="table-fn"}20[b](#tbl3fn2){ref-type="table-fn"}9[b](#tbl3fn2){ref-type="table-fn"}55[b](#tbl3fn2){ref-type="table-fn"}*p*[\*](#tbl3fn3){ref-type="table-fn"}Airspace nodules41 (44)25 (42)6 (50)19 (61)16 (80)3 (33)25 (45)0.101 Outer zone dominant24 (26)15 (25)4 (33)2 (6)1 (5)1 (11)11 (20)0.023  Lobular opacity33 (35)24 (41)3 (25)21 (68)18 (90)1 (11)20 (36)0.002  Area of airspace consolidation (AS)88 (94)58 (98)11 (92)24 (77)15 (75)9 (100)46 (84)0.017  Area of ground-glass attenuation (GG)80 (85)50 (85)8 (67)26 (84)15 (75)9 (100)49 (89)1  Lobar pneumonia28 (30)20 (34)0 (0)10 (32)7 (35)3 (33)18 (33)0.82  Bilateral areas of AS or GG40 (43)25 (42)5 (42)7 (23)3 (15)3 (33)25 (45)0.056  GG located around AS48 (51)31 (53)4 (33)9 (29)8 (40)1 (11)17 (31)0.039  Air-bronchogram85 (90)58 (98)9 (75)28 (90)20 (100)8 (89)46 (84)1  Centrilobular nodules26 (28)16 (27)4 (33)19 (61)15 (75)2 (22)18 (33)0.001 As the prominent finding2 (2)0 (0)1 (8)7 (23)5 (25)1 (11)2 (4)0.001 Outer zone dominant10 (11)6 (10)1 (8)12 (39)10 (50)1 (11)10 (18)0.001 Bilateral9 (10)5 (8)2 (17)10 (32)8 (40)0 (0)6 (11)0.007  Thickening of BVB49 (52)33 (56)6 (50)25 (81)18 (90)5 (56)29 (53)0.001  Interlobular septal thickening63 (67)43 (73)6 (50)15 (48)10 (50)4 (44)29 (53)0.087  Mediastinal adenopathy51 (54)28 (47)7 (58)13 (42)7 (35)4 (44)26 (47)0.301  Atelectasis8 (9)6 (10)1 (8)7 (23)7 (35)0 (0)6 (11)0.054[^7][^8][^9][^10]Fig. 1Mycoplasmal pneumonia in a 30-year-old woman. A transverse thin-section CT scan (1-mm collimation) through the level of the ventriculi of the heart shows ground-glass attenuation combined with centrilobular nodules (arrows) and thickened bronchial walls (arrowheads) in the left lower lobe.Fig. 2Mycoplasmal pneumonia in a 27-year-old woman. A transverse thin-section CT scan (2-mm collimation) through the level of the dome of the right diaphragm demonstrates dominant centrilobular nodules in this patient. A small area of airspace consolidation with air-bronchogram is visible (arrow).Fig. 3Mycoplasmal pneumonia in a 28-year-old man. A transverse thin-section CT scan (2-mm collimation) through the level of the ventriculi of the heart shows centrilobular nodules with poorly defined margins (arrows) located in the outer lung zone, focal areas of airspace consolidation, and ground-glass opacities. Airspace nodules more than 3 mm in size are also seen in this field.Fig. 4Pneumococcal pneumonia in a 76-year-old man. A transverse thin-section CT scan (3-mm collimation) of the left lung at the level of the carina demonstrates ground-glass attenuation around airspace consolidation. Thickening of bronchovascular bundles were also observed in bacterial pneumonias (arrows).Fig. 5Pneumococcal pneumonia in a 60-year-old man. A transverse thin-section CT scan (1-mm collimation) of the right lung at the level of the carina shows an ill-defined cluster of airspace nodules with obscured vessels located in the outer third of the right upper lobe (arrows).Fig. 6Pneumococcal pneumonia in a 29-year-old woman. A transverse thin-section CT scan (1-mm collimation) of the right lung at the level of the ventriculi of the heart shows airspace consolidations and interlobular septal thickenings (arrows) within ground-glass attenuation. Thickening of bronchial walls is also noted (arrowheads).

3.2. Multivariate logistic analysis {#section0045}
-----------------------------------

[Table 4](#tbl4){ref-type="table"} shows three logistic regression models of the dependent variables using independent thin-section CT predictor findings: "bacterial pneumonia" in models 1 and 2, and "pneumococcal pneumonia" in model 3. Six independent variables were used to compose the models of probabilities for the presence of the dependent variables. The *R* ^2^ of the models 1--3 were 0.299, 0.395 and 0.609, respectively. [Fig. 7](#fig7){ref-type="fig"} shows the ROC curves of the models described in [Table 4](#tbl4){ref-type="table"}. The areas under the ROC curves for the three models in [Table 4](#tbl4){ref-type="table"} were 0.837, 0.885 and 0.953. The optimal points on the ROC curves to discriminate between bacterial and non-bacterial pneumonias in models 1 and 2 were obtained at *P* of 0.15 and 0.35, with sensitivities of 70% and 86%, and false positive ratios of 16% and 21%, respectively. The optimal point to discriminate between pneumococcal pneumonia and mycoplasmal pneumonia in model 3 was obtained at a *P* of 0.65, with a sensitivity of 94% and a false positive ratio of 15%.Table 4Multiple logistic regression models of the three dependent variablesModelBacterial pneumonia with or without ULD[a](#tbl4fn1){ref-type="table-fn"}Bacterial pneumonia without ULD[b](#tbl4fn2){ref-type="table-fn"}Pneumococcal pneumonia without ULD[c](#tbl4fn3){ref-type="table-fn"}Independent variablesBetaS.E.*p*BetaS.E.*p*BetaS.E.*p*Intercept0.700.47--0.760.60--−1.371.99--ASN (outer zone predominance)2.010.850.00541.990.960.0213.682.020.015Lobular opacity−1.990.570.0002−2.590.69\<0.0001−3.621.350.0005CLN (outer zone predominance)−1.570.650.019−2.180.850.0057−3.841.460.0008Bilateral areas of AS or GG1.160.620.0491.510.820.0452.841.580.032Thickening of ILS1.040.570.0611.080.680.0981.671.120.11GG located around AS1.160.560.0311.270.670.0497------Areas of GG------------3.731.670.0052[^11][^12][^13][^14]Fig. 7Receiver operating characteristic (ROC) curves from six-variable logistic regression models of the dependent variables "bacterial pneumonia" (models 1 and 2) and "mycoplasmal pneumonia" (model 3). Model 1 includes 125 cases with or without underlying lung disease (ULD) and model 2 includes 90 cases without ULD. Model 3 includes 56 cases diagnosed as either pneumococcal or mycoplasmal pneumonia without ULD. Sensitivity indicates the proportion of correctly classified patients as bacterial pneumonia in models 1 and 2 (pneumococcal pneumonia in model 3), and specificity indicates the proportion of correctly classified patients as non-bacterial pneumonia in models 1 and 2 (mycoplasmal pneumonia in model 3). The areas under the ROC curves for models 1, 2, and 3 were 0.837, 0.885 and 0.953, respectively.

4. Discussion {#section0050}
=============

We have demonstrated that thin-section CT can differentiate the two types of CAPs with reasonable accuracy in selected cases without underlying lung diseases. However, large numbers of patients had to be excluded from our analysis to obtain the optimal distinction of the two types. Previous investigations showed that bacterial and non-bacterial pneumonias could not be reliably distinguished by clinical presentation and chest radiography [@bib4]. While there has been increased awareness of the utility of thin-section CT in the diagnosis of many lung diseases, including infectious cases, the role of thin-section CT in the etiological diagnosis of CAP remains to be established.

To our knowledge, only a few studies have evaluated the ability of thin-section CT to confirm the differentiation of pneumonia cases with established etiologies [@bib5], [@bib6], [@bib8], [@bib9]. Tanaka et al. showed that the frequencies of several thin-section CT findings differed significantly between two types of pneumonia. Moreover, the thin-section CT findings generally correlated well with pathogenesis and pathological findings [@bib6]. In a study that covered both immunocompetent and immunocompromised patients, Reittner et al. concluded that thin-section CT is of limited value in the differential diagnosis of infective pneumonias, even though the pneumonias caused by *M. pneumoniae* and *Pneumocystis carinii* exhibited characteristic appearances in thin-section CT [@bib5]. In previous studies, because the decisions to perform CT scans were made mostly by clinical judgment and thin-section CT studies in CAP were not performed prospectively [@bib5], [@bib6], [@bib8], [@bib9], the problem of selection bias needs to be considered. Two types of selection bias are involved: bias in selecting the examination with which to detect the causative organisms, and bias in selecting the cases to undergo thin-section CT on the basis of already known clinical information and roentgenological findings. The present study was conducted in a prospective manner in order to minimize these biases. Moreover, this study has fulfilled a need in providing a description of thin-section CT findings on pneumonias caused by the common pathogens *S. pneumoniae* and *H. influenzae* which had not been adequately described in previous thin-section CT reports.

Classical studies using experimental models [@bib15] and pathological findings [@bib16] can be helpful in explaining the thin-section CT findings of pneumococcal pneumonia in our study, which detected an inflammatory response with an outpouring of edematous fluid that rapidly spread into the adjacent parenchyma. 'Areas of GG around AS', a finding described in pneumococcal pneumonia by Reittner et al. [@bib5], was more commonly found in bacterial pneumonia than in non-bacterial pneumonia in our study. This may be due to the progression of the inflammation in bacterial pneumonias. On the other hand, the primary pathologic lesions of mycoplasma infection are known to be limited to the ciliated respiratory epithelium from the trachea to the bronchioles [@bib15]. This propensity of mycoplasma infection to affect the airways has been shown in histopathological [@bib17] and radiological [@bib5], [@bib7], [@bib18], [@bib19] studies. Our data on centrilobular nodules corroborated a study by Reittner et al., who observed the nodules in 96% of *M. pneumoniae* pneumonias and in 100% of viral pneumonias, versus only 17% of bacterial pneumonias [@bib5]. Conceivably, centrilobular nodules are specific to non-bacterial pneumonias when seen as the prominent finding (specificity of 98%), bilaterally (90%), or predominantly in the outer lung zone (89%), inasmuch as none of these localizations showed high sensitivity (23%, 39% and 32%, respectively). Patients with *H. influenzae* pneumonia often have chronic obstructive pulmonary disease, and the saprophytic bacteria within the bronchial epithelium of these cases may trigger episodes of bronchopneumonia [@bib16]. A pathologic pattern of airspace pneumonia similar to that in pneumococcal pneumonia can also occur [@bib16]. The only detectable difference between pneumococcal pneumonia and *H. influenzae* pneumonia in our study was the appearance of lobar pneumonia (0% versus 34% frequency, respectively). Chlamydial pneumonia showed similarities and differences with mycoplasmal pneumonia in thin-section CT findings [@bib8], [@bib9]. The disease showed a wide range of non-specific thin-section CT findings including both airspace pneumonia and bronchopneumonia. A histological investigation in an experimental model of Chlamydial pneumonia revealed inflammatory cell infiltration within the interstitium and alveolar space, accompanied by perivascular and peribronchiolar lymphoid cell accumulations [@bib20].

We recognize that the possibility of selection bias was not entirely eliminated, since thin-section CT was not performed on the following: patients with mild pneumonias treatable at our outpatient clinic, patients with normal chest roentogenograms in spite of respiratory symptoms, and a substantial number of cases were excluded after conventional CT scan. Further, thin-section CT examination was inapplicable to various subgroups of patients, including those with severe conditions that prevented them from holding their breath, those suffering from underlying diseases with marked distortion of the lung architecture, and those with immunocompromised conditions. Chronic obstructive pulmonary disease was one of the most frequent co-morbidities in hospitalized patients with CAP (16%) [@bib11]. Many of these were not included in this study in order to avoid misinterpretation of thin-section CT findings. In patients with immunodeficiency, a wider range of microorganisms including *Pneumocystis jirovecii*, *Aspergillus* and *Mycobacteria* can cause pneumonia [@bib5]. Consequently, six immunocompromised patients were excluded from the CT study. Investigation of immunocompromised patients is obviously needed to determine whether thin-section CT would be useful in differentiating causative organisms and should be analyzed separately from immunocompetent patients. Moreover, we were not able to evaluate CT findings of *Legionella* pneumonia because we had estimated at the outset of this study that we would have only a small number of *Legionella* cases that are more frequently encountered in Western countries based on previously reported studies [@bib11], [@bib21]. Regarding methodology, using modern picture achieving and communication systems with narrower image intervals could have enabled more accurate evaluations of the images compared to using hard-copy films. Finally, the multivariate logistic regression model employed in this study was laborious and not entirely appropriate in the daily clinical setting. Further studies in which thin-section CT findings of pneumonia are evaluated by a simpler method are clearly needed.

For thin-section CT examination to be adopted for CAP patients, the additional radiation dose and increased operational costs will need to be considered. While CT evaluation is expected to help us in narrowing the differential diagnosis in selected CAP patients, we cannot suggest the routine clinical use of this modality until its impact on clinical outcome and cost effectiveness are carefully evaluated.

In conclusion, our results indicate that variables obtained by thin-section CT findings could help in differentiating bacterial and non-bacterial pneumonias in appropriately selected cases with the application of logistic models. However, applying thin-section CT would be difficult in patients with underlying lung diseases, severe pneumonia or under immunocompromised conditions, which limit the usefulness of the examination. Although nothing specific was found for predicting a certain pathogen, the presence of airspace nodules or centrilobular nodules and data on their localization and distribution were specific predictors for both types of pneumonia.
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